We are live on ! Find out more
KTOVW

Kitov Pharma Ltd. Warrants

Delisted

KTOVW was delisted on the 23rd of November, 2020.

3 hedge funds and large institutions have $212K invested in Kitov Pharma Ltd. Warrants in 2016 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

27% more capital invested

Capital invested by funds: $167K → $212K (+$45K)

40% less funds holding

Funds holding: 53 (-2)

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
3
Holders Change
-2
Holders Change %
-40%
% of All Funds
0.07%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
Reduced
2
Closed
3
Calls
Puts
Net Calls
Net Calls Change

KTOVW Hedge Fund Activity: Q4 2016 in Review

3 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in Kitov Pharma Ltd. Warrants (KTOVW) for Q4 2016, worth a combined $212K — up 27% from $167K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of KTOVW and 1 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 0 added.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $76.9K. The largest seller was Ionic Capital Management, cutting an estimated $17.5K.

  • 3 institutional investors held Kitov Pharma Ltd. Warrants (KTOVW) as of Q4 2016, down from 5 in Q3 2016.
  • Funds reported $212K of Kitov Pharma Ltd. Warrants stock for Q4 2016, up 27% quarter-over-quarter.
  • 1 fund opened new Kitov Pharma Ltd. Warrants positions in Q4 2016 and 3 closed out, a net change of -2 holders.
  • The largest Kitov Pharma Ltd. Warrants buyer in Q4 2016 was Susquehanna International Group, an estimated $76.9K added.
  • The largest Kitov Pharma Ltd. Warrants seller in Q4 2016 was Ionic Capital Management, an estimated $17.5K sold.

Based on aggregated 13F filings for Q4 2016.